The Company received clearance for the NanoKnife System for prostate tissue ablation following the completion of the pivotal PRESERVE clinical study and submission of results to the FDA in September.
Johan Löf, founder and CEO, RaySearch: "I am very much looking forward to meeting both existing and new customers at RSNA and presenting the exciting research results regarding liver ablation and our ...
He said the procedure he was undergoing was a lung ablation, a “minimally invasive procedure that destroys tumor tissue by either heat or cooling mechanisms”, according to the Mayo Clinic. In the ...